- feeds
- popular
- recent
- reader
- about
- story
- technologies
- what is rss
- connect
- dmca
- contact
- Feed Preview News – San Diego Biotechnology Network
Bristol Myers eyes major cuts; That $1B AI startup; Pharma reacts to China bill; Q1 earnings highlights; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile t...
Computer Scientists Unveil Novel Attacks on Cybersecurity
A research team led by computer scientists at UC San Diego found two novel types of attacks that target the conditional branch predictor found in high-end Intel processors, which could be exploit...
BMS Decision to Lay Off 2,200 Employees Comes After M&A Spending Spree
Published: Apr 26, 2024 By Greg Slabodkin Pictured: A Bristol Myers Squibb sign among some bushes/iStock, arlutz73 This week, several Big Pharma companies reported first-quarter 2024 financial re...
UCB makes major management changes; Bristol Myers’ ADC partner tops list of new CEOs
Iris Loew-Friedrich ? UCB is shaking up its leadership team “to better align with its commitment to growth and innovation, and to better address the dynamic external landscape of the healthcare...
Belite Bio Announces $25 Million Registered Direct Offering
SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advan...
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024
SAN DIEGO–(BUSINESS WIRE)—- $ARCT #ClinicalTrial–Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global messenger RNA medicines company focused on t...
Scientists Discover a New Signaling Pathway and Design a Novel Drug for Liver Fibrosis
Scientists from the University of California San Diego discovered a novel signaling pathway in liver cells, leading to a treatment for fibrosis. Click here to view original post Click Here to Pub...
Higher resolution brain mapping tech wins big at Research Expo
UC San Diego electrical and computer engineering PhD student Andrew Bourhis won the top prize at the 42nd annual Jacobs School of Engineering Research Expo for his work to integrate thin film tra...
Foreign-Born Doctors Help Serve Rural and Low-Income Communities
Although about 20% of the United States population live in rural areas, only 11% of physicians practice in these locations. New research from the University of California San Diego’s School of ...
Provisio Medical Announces FDA Clearance of the Provisio SLT IVUS™ System
Groundbreaking technology for the precise, automatic measurement of peripheral blood vessels to optimize treatment strategies SAN DIEGO, April 25, 2024 /PRNewswire/ — Provisio Medical today ann...
Ionis Publishes 2023 Corporate Responsibility Report
Established new corporate responsibility strategic pillars and actionable goals Received approval for two Ionis-discovered medicines in 2023, and continued to advance a broad pipeline poised to b...
Vividion Therapeutics and Roche Jointly Publish Landmark Na...l-Stage Covalent Allosteric Inhibitor of Werner Helicase (WRN)
SAN DIEGO–(BUSINESS WIRE)–Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally undruggable targets with precisio...
STAT+: Generative AI is supposed to save doctors from burnout. New data show it needs more training
After stratospheric levels of hype, early evidence may be bringing generative artificial intelligence down to Earth. A series of recent research papers by academic hospitals has revealed signific...
Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024
SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report first quarter financial results on Wednesday, May 8, 2024, after the close of the U.S....
Cidara Therapeutics Announces Divestiture of Rezafungin to ... Advancing the Clinical Development of Cloudbreak DFC Pipeline
SAN DIEGO, April 24, 2024 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) im...
Cidara buys back flu rights, sells antifungal and inks $240M PIPE
Cidara Therapeutics announced several sweeping moves on Wednesday afternoon to bring an influenza drug back in-house and raise money from investors to back the program. The San Diego biotech said...
Artificial intelligence helps scientists engineer plants to fight climate change
LA JOLLA—The Intergovernmental Panel on Climate Change (IPCC) declared that removing carbon from the atmosphere is now essential to fighting climate change and limiting global temperature rise....
A Flexible Microdisplay Can Monitor and Visualize Brain Activity in Real-time During Brain Surgery
A thin film that combines an electrode grid and LEDs can both track and produce a visual representation of the brain’s activity in real-time during surgery–a huge improvement over the current...
Cancer testing company Freenome to lay off 100 employees
Freenome, a maker of blood-based cancer tests, will lay off more than 100 employees, or 20% of its workforce, a spokesperson for the company told Endpoints News. The job cuts come after Freenome ...
Materials Scientist Awarded Schmidt Science Fellowship
Wonjun Yim, who earned a PhD in materials science at the University of California San Diego, is one of 32 researchers selected from the world’s leading science and engineering institutions to r...
LUXE Bidet Named Hermes Creative Awards 2024 Gold Winner
SAN DIEGO, April 24, 2024 /PRNewswire/ — LUXE Bidet, the #1 bidet attachment provider in America, is delighted to share its recent success at the esteemed Hermes Creative Awards for its project...
AI-Powered Xaira Launches with $1B, Ex-Genentech Execs Look to Transform R&D
Pictured: Illustration of human hand and AI connecting/iStock Xaira Therapeutics, described as an integrated biotechnology company, launched Tuesday with $1 billion in an effort to transform drug...
Study Finds X’s Community Notes Provides Accurate Responses to Vaccine Misinformation
A new study published in JAMA finds that X’s (formerly Twitter’s) Community Notes, a crowdsourced approach to addressing misinformation, helped counter false health information in popular pos...
Endeavor Raises $132M in Oversubscribed Series C to Advance Lung Disease, ADC Candidates
Published: Apr 24, 2024 By Tyler Patchen Pictured: Photo illustration of hundred dollar bill and graph/iStock, Darren415 San Diego-based Endeavor BioMedicines has secured $132.5 million in an o...
n-Lorem Foundation Partners with Hongene Biotech Corporatio...Discovery of Personalized ASO Medicines for Nano-rare Patients
SAN DIEGO–(BUSINESS WIRE)– #ASO–Hongene to partner with n-Lorem in support of bringing personalized medicines to nano-rare patients Click here to view original post Click Here to Publish/Fe...
GenEmbryomics and Progenesis Announce Strategic Partnership to Transform IVF Testing
MELBOURNE, Australia and LA JOLLA, Calif., April 24, 2024 /PRNewswire/ — In a move that is set to transform clinical reproductive medicine, GenEmbryomics Limited, a pioneering provider of advan...
Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy
-Company Aligned with FDA on Demonstration of Non-Clinical Comparability; Allowing for Immediate Use of San Diego Manufacturing Facility- Click here to view original post Click Here to Publish/Fe...
Neurocrine Biosciences Launches WHAT THE C@H?! Educational Initiative to Support Congenital Adrenal Hyperplasia Community
WHAT THE C@H?! provides a platform for the congenital adrenal hyperplasia (CAH) community to find educational information, share experiences and learn about current research. SAN DIEGO, April 24,...
Endeavor BioMedicines snags $132M for Phase 2 fibrosis drug, ADC candidate
San Diego biotech Endeavor BioMedicines is on a tear. The startup has secured a $132.5 million Series C after hiring four C-suite leaders, licensing an antibody-drug conjugate and revealing Phase...
CSL Vifor and Travere Therapeutics Announce European Commis...s FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
First non-immunosuppressive therapy for the treatment of IgA Nephropathy (IgAN) approved in Europe Conditional marketing authorization is based on statistically significant and clinically meaning...